A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis

BACKGROUND: Insulin via continuous intravenous infusion (ICII) is a standard of care for treating patients with diabetic ketoacidosis (DKA). Once DKA is resolved, ICII is transitioned to subcutaneous therapy. However, recent guidelines recommend continuation of home dose subcutaneous basal insulin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Rappaport, Stephen H, Endicott, Jeffrey A, Gilbert, Matthew P, Farkas, Joshua D, Clouser, Ryan D, McMillian, Wesley D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500796/
https://www.ncbi.nlm.nih.gov/pubmed/31069278
http://dx.doi.org/10.1210/js.2018-00400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500796/
https://www.ncbi.nlm.nih.gov/pubmed/31069278
http://dx.doi.org/10.1210/js.2018-00400

Ejemplares similares